Trefoil Therapeutics
Dr. Macsai is an expert in corneal transplants, refractive surgery, and cataracts as well as medical and surgical treatment of diseases of the external eye. She is an author of more than 60 papers and has written numerous book chapters. Dr. Macsai is a member of the American Ophthalmologic Society with a Thesis and is a member of the Board of Directors of the Cornea Society. She is also a past president of the Society. She is Chair of the Eye Bank Association of America and has been active in eye banking at the national level for over 20 years. He received her MD degree from Rush Medical College.
This person is not in the org chart
This person is not in any offices
Trefoil Therapeutics
Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world.